Dr. Kleine Pharma Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Dr. Kleine Pharma and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 19 Dr. Kleine Pharma employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Dr. Kleine Pharma has purchased the following applications: Host Europe for Application Hosting and Computing Services in 2013, Microsoft 365 for Collaboration in 2015, Usercentrics Consent Management Platform (CMP) for Governance, Risk and Compliance in 2020 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Dr. Kleine Pharma is running and its propensity to invest more and deepen its relationship with Host Europe , GoDaddy , All-Inkl or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Dr. Kleine Pharma revenues, which have grown to $33.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Dr. Kleine Pharma intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.